A pill containing semaglutide did not perform well in clinical trials, as Novo Nordisk hoped it would
Patients should wait at least 1 month after getting filler before having a Morpheus8 or Evoke treatment
Given the elevated risk of cardiovascular morbidity and mortality in individuals with mood disorders, including bipolar disorder, the cardiovascular benefits associated with GLP-1 agonists could offer another valuable protective mechanism, enhancing the overall health and well-being of patients
Unlike existing treatments that require multiple single-use pens, Zydus' single-adjustable pen will allow patients select different doses, lowering costs
The Precision Peptide Genetic Test reviews 14 pathways, 49 peptides, 150+ genetic insights, including variants such as FTO, GLP1R, and MC4R that shape appetite and energy-balance biology